Modra Pharmaceuticals
Chris Huiskamp is a highly experienced professional who currently holds the position of Senior Vice President Clinical Business Operations at Alira Health. Prior to this, Chris has served in various high-ranking financial roles at companies such as Modra Pharmaceuticals, Isarna Therapeutics GmbH, and Assign Group. With a background in finance and extensive experience in multiple industries, Chris brings a wealth of knowledge and expertise to the table.
This person is not in the org chart
This person is not in any teams
Modra Pharmaceuticals
Modra (Modulated Oral Drug Absorption) Pharmaceuticals B.V. is a spin-out from two internationally acclaimed centers of excellence in oncology, the ‘Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL)’ and the MC Slotervaart (Slotervaart) in Amsterdam. Modra Pharmaceuticals is a clinical stage company that develops new treatment paradigms by enabling oral bioavailability of existing anticancer drugs, “the iv to oral switch”, to improve cancer therapy and supportive care. Modra Pharmaceuticals has several products in preclinical and clinical development including oral formulations of docetaxel and paclitaxel.